Document Detail


Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands.
MedLine Citation:
PMID:  20869355     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Constitutive androstane receptor (CAR) and pregnane X receptor (PXR) are closely related orphan nuclear receptor proteins that share several ligands and target overlapping sets of genes involved in homeostasis and all phases of drug metabolism. CAR and PXR are involved in the development of certain diseases, including diabetes, metabolic syndrome and obesity. Ligand screens for these receptors so far have typically focused on steroid hormone analogs with pharmacophore-based approaches, only to find relatively few new hits. Multiple CAR isoforms have been detected in human liver, with the most abundant being the constitutively active reference, CAR1, and the ligand-dependent isoform CAR3. It has been assumed that any compound that binds CAR1 should also activate CAR3, and so CAR3 can be used as a ligand-activated surrogate for CAR1 studies. The possibility of CAR3-specific ligands has not, so far, been addressed. To investigate the differences between CAR1, CAR3 and PXR, and to look for more CAR ligands that may be of use in quantitative structure-activity relationship (QSAR) studies, we performed a luciferase transactivation assay screen of 60 mostly non-steroid compounds. Known active compounds with different core chemistries were chosen as starting points and structural variants were rationally selected for screening. Distinct differences in agonist versus inverse agonist/antagonist effects were seen in 49 compounds that had some ligand effect on at least one receptor and 18 that had effects on all three receptors; eight were CAR1 ligands only, three were CAR3 only ligands and four affected PXR only. This work provides evidence for new CAR ligands, some of which have CAR3-specific effects, and provides observational data on CAR and PXR ligands with which to inform in silico strategies. Compounds that demonstrated unique activity on any one receptor are potentially valuable diagnostic tools for the investigation of in vivo molecular targets.
Authors:
Ann M Dring; Linnea E Anderson; Saima Qamar; Matthew A Stoner
Related Documents :
18555185 - Beyond receptor expression levels: the relevance of target accessibility in ligand-dire...
15204035 - G-protein coupled receptors as allosteric machines.
2538845 - Receptors and receptor binding methods in drug discovery.
19875205 - Sigma-1 ligands: tic-hydantoin as a key pharmacophore.
8916095 - The effect of gaba and 5-ht receptor antagonists on rat dorsal root potentials.
19769545 - Targeting the a2b adenosine receptor during gastrointestinal ischemia and inflammation.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-10-20
Journal Detail:
Title:  Chemico-biological interactions     Volume:  188     ISSN:  1872-7786     ISO Abbreviation:  Chem. Biol. Interact.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-12     Completed Date:  2010-12-21     Revised Date:  2011-12-21    
Medline Journal Info:
Nlm Unique ID:  0227276     Medline TA:  Chem Biol Interact     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  512-25     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antifungal Agents / chemistry,  metabolism
Biphenyl Compounds / chemistry,  metabolism
Cell Line, Tumor
Drug Evaluation, Preclinical
Histamine Antagonists / chemistry,  metabolism
Humans
Ligands
Phenolphthalein / chemistry,  metabolism
Protein Binding
Protein Isoforms / metabolism
Quantitative Structure-Activity Relationship*
Receptors, Cytoplasmic and Nuclear / metabolism*
Receptors, Steroid / metabolism*
Stilbenes / chemistry,  metabolism
Substrate Specificity
Terphenyl Compounds / chemistry,  metabolism
Grant Support
ID/Acronym/Agency:
P20 RR016457-076998/RR/NCRR NIH HHS; P20RR016157/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Antifungal Agents; 0/Biphenyl Compounds; 0/Histamine Antagonists; 0/Ligands; 0/Protein Isoforms; 0/Receptors, Cytoplasmic and Nuclear; 0/Receptors, Steroid; 0/Stilbenes; 0/Terphenyl Compounds; 0/constitutive androstane receptor; 0/pregnane X receptor; 77-09-8/Phenolphthalein; 92-52-4/diphenyl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exercise-induced plasticity of AMPA-type glutamate receptor subunits in the rat brain.
Next Document:  Simultaneous determination of polyamines in human nail as 4-(N,N-dimethylaminosulfonyl)-7-fluoro-2,1...